Eckert & Ziegler AAQS 2024
Eckert & Ziegler AAQS
7
Тикер
EUZ.DE
ISIN
DE0005659700
WKN
565970
Eckert & Ziegler ima trenutni AAQS od 7. Visok AAQS može se smatrati pozitivnim pokazateljem da se preduzeće uspešno razvija. Investitori mogu očekivati da je kompanija na dobrom putu da ostvari dobit. S druge strane, važno je posmatrati AAQS deonice Eckert & Ziegler u poređenju sa ostvarenom dobiti i drugim preduzećima iste branše. Visok AAQS nije apsolutna garancija za pozitivnu budućnost. Samo tako se može dobiti kompletna slika o performansama kompanije. Da bi se bolje procenio razvoj preduzeća, važno je posmatrati AAQS u poređenju sa drugim kompanijama iste branše. Generalno, investitori bi uvek trebali da posmatraju AAQS kompanije u kontekstu sa drugim finansijskim pokazateljima kao što su dobit, EBIT, Cash Flow i drugi, kako bi doneli obrazovane odluke o investiranju.
Eckert & Ziegler Aktienanalyse
Šta radi Eckert & Ziegler?
The Eckert & Ziegler Strahlen und Medizintechnik AG is an international company that offers both medical and industrial products and services in the field of radiation application. The company was founded in 1997 and has its headquarters in Berlin. The history of the company began in the 1960s when the two founders, Dr. Andreas Eckert and Dr. Edgar Ziegler, started producing medical isotopes for the diagnosis and therapy of cancer patients. After initially working in a laboratory in Berlin, they founded Eckert & Ziegler Isotope Products GmbH in 1983. In the following years, the company expanded and added radiation sources for industrial applications to its portfolio. In 1997, Eckert & Ziegler Strahlen und Medizintechnik AG was founded to consolidate the two business areas and expand the international business. Today, the company operates worldwide and employs over 800 people. The company's business model focuses on the application of radiation in various industries. The company relies on different business areas that can be divided into medical and industrial applications. In the medical field, Eckert & Ziegler develops and produces radiation sources for the diagnosis and therapy of cancer and other diseases. The products include radioactive isotopes used for the production of medications, the equipment of clinics, and research. Particularly important are radioactive substances for the treatment of prostate cancer, which are highly sought after due to their high effectiveness in patients. In the field of industrial applications, the company offers radiation sources for various industries, such as medical imaging, sterilization of medical devices, or non-destructive testing of materials in the automotive and aviation industries. The company also develops customized solutions for specific customer needs. Another important business area is the disposal of radioactive waste. Here, the company offers solutions for hospitals, research institutions, and companies that work with radioactive substances and must comply with legal requirements for disposal. Eckert & Ziegler is a company that focuses on innovation and research. The company continuously invests in research and development to keep its products and services up to date. For this purpose, the company maintains close relationships with research institutions and universities to develop new technologies and products. The company also strives to make its products and services environmentally friendly and sustainable. It relies on the use of renewable energies, energy efficiency, and recyclability of products. Overall, Eckert & Ziegler Strahlen und Medizintechnik AG is a leading company in the application of radiation in medical and industrial applications. The company relies on innovative products and solutions to meet the needs of its customers. Eckert & Ziegler ist eines der beliebtesten Unternehmen auf Eulerpool.com.Često postavljana pitanja o Eckert & Ziegler akciji
Plansovi za štednju u akcijama nude atraktivnu mogućnost za investitore da dugoročno izgrade bogatstvo. Jedna od glavnih prednosti je takozvani efekat prosečne cene: investiranjem redovnog fiksnog iznosa u akcije ili fondove akcija, automatski se kupuju više deonica kada su cene niske i manje kada su visoke. To može dovesti do povoljnijeg prosečnog cena po deonici tokom vremena. Pored toga, plansovi za štednju u akcijama omogućuju čak i malim ulagačima pristup skupim akcijama, pošto je moguće učestvovati već sa malim iznosima. Redovno investiranje takođe podstiče disciplinovanu strategiju ulaganja i pomaže da se izbegnu emocionalne odluke, kao što su impulsivno kupovanje ili prodaja. Osim toga, investitori profitiraju od potencijalnog povećanja vrednosti akcija kao i od isplata dividendi, koje se mogu reinvestirati, što pojačava efekat kamate na kamatu i time rast investiranog kapitala.
Akcija Eckert & Ziegler je dostupna za štedne planove kod sledećih provajdera: Trade Republic, Scalable Capital i Consorsbank
Andere Kennzahlen von Eckert & Ziegler
Naša analiza akcija za akciju Eckert & Ziegler Promet uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Eckert & Ziegler Promet. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize:
- Eckert & Ziegler Promet
- Eckert & Ziegler Dobit
- Eckert & Ziegler KGV
- Eckert & Ziegler KUV
- Eckert & Ziegler EBIT
- Eckert & Ziegler Dividenda
- Eckert & Ziegler Akcije
- Eckert & Ziegler Kapitalizacija tržišta
- Eckert & Ziegler Dugovanje
- Eckert & Ziegler Obaveze
- Eckert & Ziegler Kapital društva
- Eckert & Ziegler AAQS
- Eckert & Ziegler zaposleni
- Eckert & Ziegler ROE
- Eckert & Ziegler ROA
- Eckert & Ziegler ROCE